1
|
Zhao W, Wang J, Varghese M, Ho L, Mazzola P, Haroutunian V, Katsel PL, Gibson GE, Levine S, Dubner L, Pasinetti GM. Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects. Neuropsychiatr Dis Treat 2015; 11:565-74. [PMID: 25784811 PMCID: PMC4356684 DOI: 10.2147/ndt.s74898] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
Recent evidence shows that Alzheimer disease (AD) dementia in the oldest-old subjects was associated with significantly less amyloid plaque and fibrillary tangle neuropathology than in the young-old population. In this study, using quantitative (q) PCR studies, we validated genome-wide microarray RNA studies previously conducted by our research group. We found selective downregulation of mitochondrial energy metabolism genes in the brains of oldest-old, but not young-old, AD dementia cases, despite a significant lack of classic AD neuropathology features. We report a significant decrease of genes associated with mitochondrial pyruvate metabolism, the tricarboxylic acid cycle (TCA), and glycolytic pathways. Moreover, significantly higher levels of nitrotyrosylated (3-NT)-proteins and 4-hydroxy-2-nonenal (HNE) adducts, which are indexes of cellular protein oxidation and lipid peroxidation, respectively, were detected in the brains of oldest-old subjects at high risk of developing AD, possibly suggesting compensatory mechanisms. These findings support the hypothesis that although oldest-old AD subjects, characterized by significantly lower AD neuropathology than young-old AD subjects, have brain mitochondrial metabolism impairment, which we hypothesize may selectively contribute to the development of dementia. Outcomes from this study provide novel insights into the molecular mechanisms underlying clinical dementia in young-old and oldest-old AD subjects and provide novel strategies for AD prevention and treatment in oldest-old dementia cases.
Collapse
Affiliation(s)
- Wei Zhao
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA
| | - Jun Wang
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA
| | - Merina Varghese
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Lap Ho
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA
| | - Paolo Mazzola
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy
| | - Vahram Haroutunian
- Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Pavel L Katsel
- Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Gary E Gibson
- Department of Neurology and Neuroscience, Weill Cornell Medical College, Burke Medical Research Institute, New York, NY, USA
| | - Samara Levine
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Lauren Dubner
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Giulio Maria Pasinetti
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Geriatric Research Education Clinical Center - James J Peter VA Medical Center, Bronx, NY, USA ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA ; Department of Geriatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| |
Collapse
|
3
|
Domínguez YL, Hernández M, Matos CM, Zhou D. Is B vitamins deficiency associated with prevalence of Alzheimer's disease in Cuban elderly? Nutr Health 2006; 18:103-18. [PMID: 16859173 DOI: 10.1177/026010600601800202] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Alzheimer's disease (AD), is a major public health problem among the elderly in industrialized countries and a growing problem in developing countries. In Cuba, 14,6% of the population is older than 60 years. The AD prevalence in Cuba lies between 5,13-7,14%. Several studies have shown the relationship between the low nutritional status of B vitamins, hyperhomocysteinaemia with loss of neuro-cognitive function and AD. In studies during the epidemic neuropathy that affected Cuba between 1992-1993, B vitamins deficiency and smoking habits were strongly associated with the epidemic. Some studies in healthy adults and elderly after this epidemic have shown a sub-clinical deficiency of some B vitamins and a high prevalence of infection by Helicobacter pylori. The possibility that B vitamin deficiencies could be an additional risk factor for the high prevalence of the AD in Cuba is discussed.
Collapse
Affiliation(s)
- Yeneisy Lanyau Domínguez
- Institute of Nutrition and Food Hygiene, Department of Biochemistry and Physiology Havana, Cuba.
| | | | | | | |
Collapse
|
4
|
Pridgeon JW, Geetha T, Wooten MW. A Method to Identify p62's UBA Domain Interacting Proteins. Biol Proced Online 2003; 5:228-237. [PMID: 14702098 PMCID: PMC302190 DOI: 10.1251/bpo66] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2003] [Revised: 11/19/2003] [Accepted: 11/20/2003] [Indexed: 11/30/2022] Open
Abstract
The UBA domain is a conserved sequence motif among polyubiquitin
binding proteins. For the first time, we demonstrate a systematic, high
throughput approach to identification of UBA domain-interacting proteins from a
proteome-wide perspective. Using the rabbit reticulocyte lysate in
vitro expression cloning system, we have successfully identified eleven
proteins that interact with p62’s UBA domain, and the majority of the eleven
proteins are associated with neurodegenerative disorders, such as Alzheimer’s
disease. Therefore, p62 may play a novel regulatory role through its UBA
domain. Our approach provides an easy route to the characterization of UBA
domain interacting proteins and its application will unfold the important roles
that the UBA domain plays.
Collapse
Affiliation(s)
- Julia W. Pridgeon
- Department of Biological Sciences, Program in Cellular and
Molecular Biosciences. 331 Funchess Hall, Auburn University, Auburn, AL 36849.
USA
| | - Thangiah Geetha
- Department of Biological Sciences, Program in Cellular and
Molecular Biosciences. 331 Funchess Hall, Auburn University, Auburn, AL 36849.
USA
| | - Marie W. Wooten
- Department of Biological Sciences, Program in Cellular and
Molecular Biosciences. 331 Funchess Hall, Auburn University, Auburn, AL 36849.
USA
| |
Collapse
|
5
|
Abstract
High-performance liquid chromatographic methods for the determination of thiamine (vitamin B1) in foodstuffs or biological tissues and fluids are outlined and discussed. The methods are often similar and interchangeable, sample extraction and clean up procedures being the major difference. Most of the methods use either ultraviolet or fluorescence detection. Fluorescence detection requires either precolumn or postcolumn oxidation of thiamine to thiochrome. A number of methods are recommended and problems with standardization are emphasized.
Collapse
Affiliation(s)
- P L Lynch
- Department of Clinical Chemistry, Altnagelvin Area Hospital, Londonderry, Northern Ireland, UK
| | | |
Collapse
|
6
|
Lynch PL, Trimble ER, Young IS. High-performance liquid chromatographic determination of thiamine diphosphate in erythrocytes using internal standard methodology. JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL SCIENCES AND APPLICATIONS 1997; 701:120-3. [PMID: 9389346 DOI: 10.1016/s0378-4347(97)00353-8] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
A high-performance liquid chromatography method for the determination of thiamine diphosphate (vitamin B1) in erythrocytes is presented. The method is robust, accurate and reproducible and due to the use of acetylaneurine as an internal standard, offers advantages over previous methods.
Collapse
Affiliation(s)
- P L Lynch
- Department of Clinical Biochemistry, The Royal Group of Hospitals, Belfast, UK
| | | | | |
Collapse
|
7
|
Abstract
Fursultiamine (TTFD), a derivative of thiamine, at an oral dose of 100 mg/day had a mild beneficial effect in patients with Alzheimer's disease in a 12-week open trial. The improvement could be observed not only in their emotional or other mental symptoms but also in intellectual function. Only mildly impaired subjects showed cognitive improvement. Alzheimer patients' blood levels of thiamine before the trial were within the normal range. No adverse reactions were observed and all patients tolerated the trial well. TTFD could afford an alternate treatment to large doses of thiamine hydrochloride in Alzheimer patients. However, further investigations of the therapeutic implications of thiamine and its possible etiologic clues to Alzheimer's disease are necessary.
Collapse
Affiliation(s)
- Y Mimori
- Third Department of Internal Medicine, Hiroshima University School of Medicine, Japan
| | | | | |
Collapse
|
8
|
Dodd PR, Thomas GJ, McCloskey A, Crane DI, Smith ID. The neurochemical pathology of thiamine deficiency: GABAA and glutamateNMDA receptor binding sites in a goat model. Metab Brain Dis 1996; 11:39-54. [PMID: 8815389 DOI: 10.1007/bf02080930] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Synaptic plasma membranes were prepared from four cerebrocortical areas from six male Angora goats made chronically thiamine deficient (TD) by the administration of AmproliumTM (600-900 mg/kg daily for 38-44 d). Four male controls were matched for age (27-30 mo). Four different radioligands were used to characterise GABAA and Glu-RNMDA receptor binding sites. There were marked, localised and contrasting changes in motor cortex, with an increase in GABAA and a decrease in Glu-RNMDA binding site densities. Less clearcut changes of a similar nature were seen in visual cortex. There was no variation in the parameters of GABA-activated [3H]diazepam binding between cortical areas in control goats, but there was a reduction in the maximal response to GABA in all areas in TD goats. There were regional variations in glutamate-activated [3H]MK-801 binding in control goat brain, and a non-selectively reduced maximal response in TD. Alterations in these indices of GABA- and glutamate-mediated neurotransmission may underlie the neurological signs of acute thiamine deficiency in these animals.
Collapse
Affiliation(s)
- P R Dodd
- Clinical Research Laboratory, Royal Brisbane Hospital Research Foundation, Australia
| | | | | | | | | |
Collapse
|